医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集
▼×

バイオテクノロジー

SanBio Names Mohammad El-Kalay New Technical Operations SVP

SanBio Names Mohammad El-Kalay New Technical Operations SVP

バイオテクノロジーヘルスケア幹細胞臨床試験製薬遺伝学　 TimeLine: SanBio Names Mohammad El-Kalay New Technical

2017年09月25日

0

Evaluate Ltd: Worldwide Medtech Sales Forecast to Reach $522 Billion by 2022 with a CAGR of 5.1% between 2016 and 2022

Evaluate Ltd: Worldwide Medtech Sales Forecast to Reach $522 Billion by 2022 with a CAGR of 5.1% between 2016 and 2022

バイオテクノロジーヘルスケア製薬　 TimeLine: between 2016 and 2022 by 2022 with a CAGR of 5.1%Evaluate Ltd Worldwide Medtech Sales Forecast to Reach

2017年09月25日

0

China Food and Drug Administration Approves Gilead’s Sovaldi® (Sofosbuvir) for Treatment of Chronic Hepatitis C Virus Infection

China Food and Drug Administration Approves Gilead’s Sovaldi® (Sofosbuvir) for Treatment of Chronic Hepatitis C Virus Infection

バイオテクノロジーヘルスケア感染症病院臨床試験製薬　 TimeLine: China Food and Drug Administration Approves for Treatment of Chronic Hepatitis C Virus

2017年09月25日

0

Konica Minolta Accelerates Expansion of Precision Medicine Business Through Acquisition of US-based Pharmaceutical Research Company, Invicro

Konica Minolta Accelerates Expansion of Precision Medicine Business Through Acquisition of US-based Pharmaceutical Research Company, Invicro

バイオテクノロジーヘルスケア医療機器腫瘍学臨床試験製薬　 TimeLine: Konica Minolta Accelerates Expansion of Precision Through Acquisition of US-based Pharmaceutical

2017年09月25日

0

Internationally Renowned Virologist Christian Bréchot Appointed President of the Global Virus Network (GVN)

Internationally Renowned Virologist Christian Bréchot Appointed President of the Global Virus Network (GVN)

バイオテクノロジーヘルスケアヘルス一般感染症製薬　 TimeLine: Internationally Renowned Virologist Christian Br President of the Global Virus Network

2017年09月25日

0

Exelixis Provides Update on Collaborator Daiichi Sankyo’s Phase 3 Clinical Progress with Esaxerenone (CS-3150), Including Positive Top-Line Results and Additional Pivotal Study

Exelixis Provides Update on Collaborator Daiichi Sankyo’s Phase 3 Clinical Progress with Esaxerenone (CS-3150), Including Positive Top-Line Results and Additional Pivotal Study

バイオテクノロジーヘルスケア心臓学糖尿病腫瘍学臨床試験製薬　 TimeLine: Clinical Progress with Esaxerenone Exelixis Provides Update on Collaborator Daiichi Top-Line Results and Additional Pivotal Study

2017年09月25日

0

Avita Medical and BARDA Execute a US$24.3m Contract Option

Avita Medical and BARDA Execute a US$24.3m Contract Option

その他ヘルスバイオテクノロジーヘルスケア医療機器医療用品外科病院製薬　 TimeLine: Avita Medical and BARDA Execute a US

2017年09月21日

0

Eagle Pharmaceuticals Licenses Japanese Rights for Bendamustine Hydrochloride Ready-to-dilute and Rapid Infusion Injection Products to SymBio Pharmaceuticals Limited

Eagle Pharmaceuticals Licenses Japanese Rights for Bendamustine Hydrochloride Ready-to-dilute and Rapid Infusion Injection Products to SymBio Pharmaceuticals Limited

バイオテクノロジーヘルスケア医療用品腫瘍学製薬　 TimeLine: Eagle Pharmaceuticals Licenses Japanese Rights for Hydrochloride Ready-to-dilute and Rapid Infusion SymBio Pharmaceuticals Limited

2017年09月20日

0

Arcus Biosciences Announces Option and License Agreement with Taiho Pharmaceutical Co. Ltd.

Arcus Biosciences Announces Option and License Agreement with Taiho Pharmaceutical Co. Ltd.

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬　 TimeLine: Arcus Biosciences Announces Option and License

2017年09月20日

0

Cardihab Cardiac Rehab App Spun out of CSIRO eHealth Division

Cardihab Cardiac Rehab App Spun out of CSIRO eHealth Division

バイオテクノロジーヘルスケア医療機器医療管理心臓学　 TimeLine: Cardihab Cardiac Rehab App Spun out

2017年09月19日

0